Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suxing Liu

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Scientific Reports|April 29, 2021
Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasisSuxing Liu, Dong Liu, Ru Shen, et al.
ACS Pharmacology & Translational Science|July 15, 2022
Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of OsteoarthritisPeng Zhao, Dong Liu, Chunying Song, et al.
Oncogene|April 20, 2002
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathwayAsra Mirza, Marnie McGuirk, Tish N Hockenberry, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of novel spiro compound as RAF kinase inhibitor with in vitro potency against KRAS mutant cancerPeng Zhao, Xiangzhu Wang, Linghang Zhuang, et al.
Oncotargets and Therapy|September 1, 2021
A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast CancerSuxing Liu, Di Li, Jian Liu, et al.
Peerj|December 7, 2017
PlantCV v2: Image analysis software for high-throughput plant phenotypingMalia A Gehan, Noah Fahlgren, Arash Abbasi, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor ActivityBiao Lu, Dong Liu, Bin Gui, et al.
Scientific Reports|May 20, 2022
SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosisChunying Song, Dong Liu, Suxing Liu, et al.
Frontiers in Immunology|June 13, 2022
Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling PathwaysYu Zhou, Xin Li, Ru Shen, et al.
European Journal of Medicinal Chemistry|December 15, 2021
Discovery of spiro amide SHR902275: A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancersPeng Zhao, Linghang Zhuang, Xiangzhu Wang, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Scientific Reports|April 29, 2021
Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasisSuxing Liu, Dong Liu, Ru Shen, et al.
ACS Pharmacology & Translational Science|July 15, 2022
Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of OsteoarthritisPeng Zhao, Dong Liu, Chunying Song, et al.
Oncogene|April 20, 2002
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathwayAsra Mirza, Marnie McGuirk, Tish N Hockenberry, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of novel spiro compound as RAF kinase inhibitor with in vitro potency against KRAS mutant cancerPeng Zhao, Xiangzhu Wang, Linghang Zhuang, et al.
Oncotargets and Therapy|September 1, 2021
A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast CancerSuxing Liu, Di Li, Jian Liu, et al.
Peerj|December 7, 2017
PlantCV v2: Image analysis software for high-throughput plant phenotypingMalia A Gehan, Noah Fahlgren, Arash Abbasi, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor ActivityBiao Lu, Dong Liu, Bin Gui, et al.
Scientific Reports|May 20, 2022
SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosisChunying Song, Dong Liu, Suxing Liu, et al.
Frontiers in Immunology|June 13, 2022
Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling PathwaysYu Zhou, Xin Li, Ru Shen, et al.
European Journal of Medicinal Chemistry|December 15, 2021
Discovery of spiro amide SHR902275: A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancersPeng Zhao, Linghang Zhuang, Xiangzhu Wang, et al.
Pageof 4